BioCrossroads CEO Martin to step down in April
Patty Martin, president and CEO of BioCrossroads since 2019, said she plans to leave the organization to examine opportunities in the private sector.
Patty Martin, president and CEO of BioCrossroads since 2019, said she plans to leave the organization to examine opportunities in the private sector.
Neuraxis Inc., based in Versailles and with an office in Carmel, said it will use the proceeds to ramp up its sales and marketing efforts, along with research and development and other functions.
Researchers at Indiana University School of Medicine are hoping to gain new insights into the defect, called coarctation of the aorta, or narrowing of the aorta that obstructs blood flow to vital organs.
The Legislature is considering a bill that put Indiana on a list of more than a dozen other states that expressly prohibit or sharply limit non-compete agreements for physicians and other patient-care professionals.
Hospitals across the state experienced their most difficult financial year in 2022 since the beginning of the pandemic, according to a study released Wednesday by the Indiana Hospital Association.
The settlement with St. Louis-based health insurer Centene Corp. resolves allegations that the company overcharged Indiana’s Medicaid program for pharmaceutical costs.
The money will be used to provide new opportunities for graduate students typically underrepresented in biomedical science, officials said.
Some public interest groups say the rising tide of anonymous gifts to not-for-profits can lead to potential fraud or dark-money abuses, so the groups have pushed to require institutions to list their big givers.
It’s the latest in a series of bills meant to address the high cost of health care in Indiana, as well as the physician shortage and patients’ rights.
The move will create at least 100 new jobs at the plant, located in Research Triangle Park, the largest research park in the country.
The two companies said the combination builds on a seven-year collaboration in Louisiana through joint ownership of Healthy Blue, which serves Medicaid and Medicare Dual Eligible members.
The amount raised last year is roughly 43% larger than the previous record of $433 million, set in 2021, according to BioCrossroads, an Indianapolis-based group that promotes and invests in the state’s life-sciences sector and tracks the funding.
Altogether, not-for-profit institutions in Indiana landed 54 gifts of $1 million or more in 2022, for a total of $241 million, or nearly 8% higher than a year ago. Purdue University received five of the top 10 donations.
Donanemab’s ability to rapidly remove amyloid beta from patients’ brains prevented the required number of patients from receiving the drug for a full 12 months, Lilly said, resulting in the FDA rejection.
Not-for-profit organizations in Indiana would be permitted to keep the identity of their members and donors secret under a bill now advancing through the Indiana General Assembly.
Indianapolis-based utility AES Indiana has agreed to reduce the amount it will charge customers for costs related to the breakdown of its newest power plant from $71 million to $13.7 million under a settlement agreement approved Wednesday by state regulators.
The Indianapolis company, located in the former St. Bernadette Catholic Church on the near-east side, plans to make the hires by the end of 2025.
Patients Choice Laboratories said Friday it was “appalled” by the comments of its employee, who sent a vulgar, threatening direct message to Democratic Rep. Eric Swalwell.
The not-for-profit Tumaini Foundation for Global Health and Humanitarianism says it wants to train medical students with a special concern for the health of needy individuals and populations worldwide.
Upset with what they say is the excessive cost of health care in Indiana, House Republicans want to levy fines against hospitals that charge more than 260% of what Medicare reimburses for services.